Sun Pharma Advanced Research Company Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 165.6 million compared to INR 476.9 million a year ago. Revenue was INR 209.6 million compared to INR 584.2 million a year ago.

Net loss was INR 1,057.9 million compared to INR 819.9 million a year ago. Basic loss per share from continuing operations was INR 3.26 compared to INR 2.55 a year ago. Diluted loss per share from continuing operations was INR 3.26 compared to INR 2.55 a year ago.